Structured Summary
Abstract
An oral chrysotherapeutic agent for the treatment of rheumatoid arthritis. Its exact mechanism of action is unknown, but it is believed to act via immunological mechanisms and alteration of lysosomal enzyme activity. Its efficacy is slightly less than that of injected gold salts, but it is better tolerated, and side effects which occur are potentially less serious.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
7 entry terms
- Crisinor
- Ridaura
- Ridauran
- SK&F D 39162
- SK&F-39162
- SK&F 39162
- SK&F39162
MeSH Record
Aspects Covered
25 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analogs & derivatives, analysis, antagonists & inhibitors, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.
MeSH Record
History Note
87
MeSH Record
Previous Indexing
- Gold (1966-1974)
- Gold Thioglucose/analogs & derivatives (1975-1986)
MeSH Hierarchy
Tree Number
AMA Style
References
- National Library of Medicine. Auranofin. Medical Subject Headings (MeSH). 2026. Unique ID D001310. http://id.nlm.nih.gov/mesh/2026/D001310
- Auranofin. In: Wikipedia. https://en.wikipedia.org/wiki/Auranofin
- Auranofin. In: Wikidata. https://www.wikidata.org/wiki/Q421230